You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treg

Showing 26 - 50 of 758
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic GVHD Trial in Bologna (T reg DLI)

Recruiting
  • Chronic Graft Versus Host Disease
  • T reg DLI
  • Bologna, BO, Italy
    University Hospital St. Orsola-Malpighi Polyclinic
Jan 14, 2021

Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19

Completed
  • Disease, Viral
  • +2 more
  • Cytokines measurement
  • +3 more
  • Madrid, Spain
    Hospital Ramon y Cajal
Jan 11, 2021

GVHD, Allogeneic Hematopoietic Cell Transplant Recipient Trial in Palo Alto (Regulatory T Cells)

Completed
  • Graft Versus Host Disease
  • Allogeneic Hematopoietic Cell Transplant Recipient
  • Regulatory T Cells
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 20, 2021

Prospective Study of White Blood Cells

Recruiting
  • Autoimmune Diseases
  • +2 more
  • White blood cell and blood collection
  • London, United Kingdom
    Quell Investigator Site 01
Apr 6, 2021

Type 1 Diabetes Trial in San Francisco, New Haven (PolyTregs+IL-2)

Completed
  • Type 1 Diabetes Mellitus
  • PolyTregs+IL-2
  • San Francisco, California
  • +1 more
Oct 15, 2021

Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK

Recruiting
  • RCC
  • Metastatic Renal Cell Carcinoma
  • Immunological and tumour characterization
  • Naples, Italy
    IRCCS Istituto Nazionale Tumori di Napoli
Sep 10, 2020

Diabetes, Type 1 Trial in Changsha (Umbilical Cord Blood Regulatory T cells Therapy, Insulin)

Recruiting
  • Diabetes Mellitus, Type 1
  • Umbilical Cord Blood Regulatory T cells Therapy
  • Insulin
  • Changsha, Hunan, China
    Institute of Metabolism and Endocrinology, Second Xiangya Hospit
Mar 24, 2021

High Risk Hematologic Malignancies Trial in Salt Lake City (stem cell transplant, Stem cell transplant)

Terminated
  • High Risk Hematologic Malignancies
  • stem cell transplant
  • Stem cell transplant
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 10, 2020

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • +5 more
  • Purified regulatory T-cells (Treg) plus CD34+ HSPC
  • +7 more
  • Stanford, California
    Stanford University
Oct 28, 2021

Type1 Diabetes, Autoimmune Diabetes Trial in Changsha (Liraglutide, UCB-Treg, Insulin)

Recruiting
  • Type1 Diabetes Mellitus
  • Autoimmune Diabetes
  • Changsha, Hunan, China
    Institute of Metabolism and Endocrinology, Second Xiangya Hospit
Mar 24, 2021

Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

Recruiting
  • Myeloid Leukemia, Chronic
  • +8 more
  • Conventional T cells (Tcon) and Regulatory T cells (Treg)
  • Palo Alto, California
    Stanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021

Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • +17 more
  • Infusion of Treg
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Sep 8, 2020

Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content, Head Neck Cancer Squamous Cell Carcinoma, NSCLC Trial in

Recruiting
  • Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
  • +12 more
  • Palo Alto, California
  • +9 more
Mar 24, 2022

Breg and Treg With Clinical Effects of Infliximab in Treatment

Completed
  • Crohn Disease
  • Wenzhou, Zhejiang, China
    SAHWenzhouMU
Feb 13, 2020

Amyotrophic Lateral Sclerosis Trial in France, United Kingdom (Riluzole, IL-2, 5% glucose water solution)

Completed
  • Amyotrophic Lateral Sclerosis
  • Lille, France
  • +16 more
Apr 1, 2022

Type 1 Diabetes Trial in Changsha (Porcine islets, Autologous Treg)

Completed
  • Type 1 Diabetes
  • Porcine islets
  • Autologous Treg
  • Changsha, Hunan, China
    Cell Transplantation and Gene Therapy Institute
May 29, 2020

TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid

Not yet recruiting
  • TIA
  • +2 more
  • Interleukin-2 [IL-2]
  • Standard care - Carotid Endarterectomy
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrookes Hospital
Aug 2, 2023

Interleukins in Periodontal Disease Progression

Recruiting
  • Periodontitis
  • Gingivitis
  • Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
  • Assiut, Asyut, Egypt
    Department of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myeloproliferative Disorders Trial in Perugia (High dose irradiation

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • High dose irradiation conditioning + Treg/Tcon
  • Perugia, PG, Italy
    University of Perugia
Jan 8, 2020

Microparticle Delivered STING Agonist in Control of Experimental

Recruiting
  • Relapse Remitting Multiple Sclerosis
  • Blood Draw
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jan 20, 2023

Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)

Not yet recruiting
  • Lupus Nephritis
  • Type 1 Diabetes Mellitus
  • autologous adoptive T regulatory cell transfer.
  • Cairo, Egypt
    Ain shams university, faculty of medicine
Sep 30, 2022

Alopecia Areata Trial in France (IL2, )

Completed
  • Alopecia Areata
  • Marseille, Bouche Du Rhône, France
  • +5 more
Dec 3, 2019

Chronic Heart Failure Patients Trial (Eprolidone)

Not yet recruiting
  • Chronic Heart Failure Patients
  • (no location specified)
Jun 28, 2023

Alzheimer Trial in Houston (Aldesleukin)

Completed
  • Alzheimer Disease
  • Houston, Texas
    Alireza Faridar
Apr 19, 2023

End Stage Renal Disease Trial in Lexington (High Intensity Interval Training)

Not yet recruiting
  • End Stage Renal Disease
  • High Intensity Interval Training
  • Lexington, Kentucky
    University of Kentucky Transplant Center
Feb 14, 2022